Your browser doesn't support javascript.
loading
Outcomes of patients with CLL sequentially resistant to both BCL2 and BTK inhibition.
Lew, Thomas E; Lin, Victor S; Cliff, Edward R; Blombery, Piers; Thompson, Ella R; Handunnetti, Sasanka M; Westerman, David A; Kuss, Bryone J; Tam, Constantine S; Huang, David C S; Seymour, John F; Roberts, Andrew W; Anderson, Mary Ann.
Afiliação
  • Lew TE; Department of Clinical Haematology, The Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Lin VS; Blood Cells and Blood Cancer Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
  • Cliff ER; Department of Clinical Haematology, The Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Blombery P; Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Parkville, VIC, Australia.
  • Thompson ER; Department of Clinical Haematology, The Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Handunnetti SM; Department of Clinical Haematology, The Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Westerman DA; Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Parkville, VIC, Australia.
  • Kuss BJ; Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Tam CS; Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Huang DCS; Department of Clinical Haematology, The Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Seymour JF; Department of Clinical Haematology, The Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Roberts AW; Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Parkville, VIC, Australia.
  • Anderson MA; Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
Blood Adv ; 5(20): 4054-4058, 2021 10 26.
Article em En | MEDLINE | ID: mdl-34478505

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Linfoma Difuso de Grandes Células B / Antineoplásicos Tipo de estudo: Observational_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Linfoma Difuso de Grandes Células B / Antineoplásicos Tipo de estudo: Observational_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article